GE’s Value Of Knowing Survey 2014
The GE Healthcare-sponsored Value of Knowing Survey 2014 revealed an overwhelming demand among participants to know about a neurological diagnosis in themselves or people close to them, even if the disorder was incurable.
You may also be interested in...
GE Healthcare has complemented its in-house R&D with a successful life sciences licensing business. Sian Godwin, head of licensing for Life Sciences, explains the group’s priorities and modus operandi.
Confidence in the vaccine has slipped in the US, regardless of political affiliation.
Effectiveness can be evaluated more quickly because researchers won’t have to wait for the second dose, company executive notes during briefing on the launch of the Phase III study.